Abstract
Bronchiolitis obliterans (BO) is the most frequent late-onset noninfectious pulmonary complication following an allogeneic hematologic stem cell transplantation attributed to chronic lung graft-versus-host disease. Its management is usually a great challenge when considering both the diagnosis and the treatment. The definite diagnosis relies on histological examination; however, lung biopsies are rarely available. The diagnosis must then be retained for converging arguments based on clinical and radiological features and pulmonary function testing. However, clinical, radiological and functional characteristics of patients with BO may be various, leading to difficulties in diagnosis. Furthermore, the treatment of BO is currently a controversial issue, and its evaluation is limited by not knowing the natural history. Herein, through a demonstrative case study, we discuss the diagnostic and therapeutic approach for a patient with a biopsy-proven BO following allogeneic stem cell transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afessa B, Peters SG (2005) Chronic lung disease after hematopoietic stem cell transplantation. Clin Chest Med 26: 571–586, vi
Bashoura L, Gupta S, Jain A et al (2008) Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 41: 63–67
Bergeron A, Belle A, Chevret S et al (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39:547–553
Chan CK, Hyland RH, Hutcheon MA et al (1987) Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 66:327–340
Clark JG, Crawford SW, Madtes DK et al (1989) Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 111: 368–376
Dudek AZ, Mahaseth H, DeFor TE et al (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9:657–666
Erard V, Chien JW, Kim HW et al (2006) Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 193:1619–1625
Filipovich AH, Weisdorf D, Pavletic S et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956
Franquet T, Muller NL (2003) Disorders of the small airways: high-resolution computed tomographic features. Semin Respir Crit Care Med 24:437–444
Gerhardt SG, McDyer JF, Girgis RE et al (2003) Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 168: 121–125
Gulbahce HE, Baker KS, Kumar P et al (2003) Atypical cells in bronchoalveolar lavage specimens from bone marrow transplant recipients. A potential pitfall. Am J Clin Pathol 120:101–106
Gunn ML, Godwin JD, Kanne JP et al (2008) High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 23:244–250
Hallstrand TS, Sprenger JD, Agosti JM et al (2004) Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 104:3086–3090
Khalid M, Al Saghir A, Saleemi S et al (2005) Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 25:490–493
Maimon N, Lipton JH, Chan CK et al (2009) Macrolides in the treatment of bronchiolitis obliterans in allograft recipients. Bone Marrow Transplant 44:69–73
Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
Philit F, Wiesendanger T, Archimbaud E et al (1995) Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 8:551–558
Rochat I, Posfay-Barbe KM, Kumar N et al (2008) Bronchoalveolar cytology for diagnosing pulmonary GVHD after bone marrow transplant in children. Pediatr Pulmonol 43:697–702
Santo Tomas LH, Loberiza FR Jr, Klein JP et al (2005) Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 128: 153–161
Sargent MA, Cairns RA, Murdoch MJ et al (1995) Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT. AJR Am J Roentgenol 164:693–696
St John RC, Gadek JE, Tutschka PJ et al (1990) Analysis of airflow obstruction by bronchoalveolar lavage following bone marrow transplantation. Implications for pathogenesis and treatment. Chest 98:600–607
White DA, Wong PW, Downey R (2000) The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161:723–729
Williams KM, Chien JW, Gladwin MT et al (2009) Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 302:306–314
Yousem SA (1995) The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 26:668–675
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bergeron, A., Feuillet, S., Meignin, V., Ribaud, P., Tazi, A. (2011). Respiratory Symptoms Occurring 4 Months After Allogeneic Hematopoietic Stem Cell Transplantation. In: Azoulay, E. (eds) Pulmonary Involvement in Patients with Hematological Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15742-4_58
Download citation
DOI: https://doi.org/10.1007/978-3-642-15742-4_58
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15741-7
Online ISBN: 978-3-642-15742-4
eBook Packages: MedicineMedicine (R0)